NCT01099839

A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol

A Phase I Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: Male
• Age: 20 Years – 44 Years
• Healthy volunteers: Accepted

Summary

This study is to assess the pharmacokinetic interaction between ASP1941 and Miglitol in healthy volunteers.

Detailed description

This will be a randomized, open-label, 3-way crossover design study to assess the drug-drug interaction between a single oral dose of ASP1941 and a single oral dose of Miglitol in healthy adult male volunteers. Each subject will receive "ASP1941 alone", "Miglitol alone" and "ASP1941 + Miglitol".

Conditions

• Healthy Volunteers
• Pharmacokinetics of ASP1941

Interventions

Type	Name	Description
DRUG	ASP1941	oral
DRUG	Miglitol	oral

Timeline

• Start date: 2010-02-01
• Primary completion: 2010-04-01
• Completion: 2010-04-01
• First posted: 2010-04-08
• Last updated: 2010-06-09

Locations

1 site across 1 country: Japan